StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
112
This month
2
This week
1
This year
5
Today
1
Yesterday
1
Publishing Date
2023 - 10 - 30
2
2022 - 10 - 20
2
2022 - 09 - 29
2
2022 - 05 - 11
2
2022 - 04 - 12
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 18
1
2022 - 03 - 17
1
2022 - 02 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 17
1
2022 - 01 - 06
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 18
1
2021 - 11 - 16
1
2021 - 11 - 12
2
2021 - 11 - 10
1
2021 - 11 - 09
2
2021 - 11 - 04
1
2021 - 10 - 26
1
2021 - 10 - 19
1
2021 - 10 - 15
2
2021 - 09 - 28
1
2021 - 09 - 27
1
2021 - 09 - 24
1
2021 - 09 - 22
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 08 - 30
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 02
1
2021 - 07 - 29
1
2021 - 07 - 21
1
2021 - 07 - 12
1
2021 - 07 - 01
1
2021 - 06 - 22
2
2021 - 06 - 16
1
2021 - 06 - 09
1
2021 - 06 - 07
1
2021 - 06 - 03
1
2021 - 05 - 28
1
2021 - 05 - 27
1
2021 - 05 - 25
1
2021 - 05 - 24
1
2021 - 04 - 08
1
2021 - 03 - 29
1
2021 - 03 - 24
1
2021 - 03 - 18
2
2021 - 03 - 15
1
2021 - 03 - 11
1
2021 - 01 - 05
1
Sector
Commercial services
1
Finance
6
Finance and insurance
3
Health technology
112
Professional, scientific, and technical services
3
Tags
Acquire
1
Acquisition
1
Agreement
3
Alcohol use disorder
3
Alliances
4
Application
2
Biotechnology
5
Cancer
4
Clearance
3
Clinical-trials-phase-iii
2
Collaboration
5
Conference
15
Disease
4
Drug
3
Earnings
8
Europe
7
Events
22
Expansion
2
Fda
5
Financial
4
Financial results
4
Genetown
7
Insulin
2
Iph5201
2
Kidney
2
Leo
3
License
5
Liver
4
Liver disease
3
Living
2
Mergers-and-acquisitions
3
Money
7
Nash
3
New drug
2
News
2
Obesity
2
Partnership
2
People
11
Pharm-country
4
Pharma
48
Pharmaceutical
12
Phase 1
4
Phase 2
5
Phase 3
2
Platform
3
Preclinical
2
Product-news
3
Rare
2
Regulatory
2
Report
2
Research
12
Results
13
Sanofi
3
Spac
4
Space
4
Therapeutics
8
Treatment
9
Trial
14
Update
6
Year
2
Entities
2seventy bio, inc.
1
Abbott laboratories
1
Akebia therapeutics, inc.
1
Alnylam pharmaceuticals, inc.
22
Aptevo therapeutics inc.
1
Astrazeneca plc
5
Bnp paribas
3
Bristol-myers squibb company
1
Bruker corporation
1
Catalent, inc.
1
Charles river laboratories international, inc.
1
Cyclo therapeutics inc - class a
1
Denali therapeutics inc.
1
Eli lilly and company
22
Gilead sciences, inc.
1
Glaxosmithkline plc
2
Homestreet, inc.
1
Innate pharma s.a.
46
Innate pharma sa
43
Insulet corporation
2
Johnson & johnson
5
Kamada ltd.
1
Morgan stanley
1
Morphosys ag
1
Novo nordisk a/s
112
Precision biosciences, inc.
1
Prothena corporation plc
1
Rallybio corp
1
Royalty pharma plc
1
Sanofi
47
Spruce biosciences, inc.
1
Svb financial group
1
Takeda pharmaceutical company limited
1
Uniqure n.v.
2
Vectivbio holding ag
2
Zealand pharma a/s
2
Symbols
A
114
ABBV
240
ABT
223
ALNY
161
AMGN
173
AMRN
173
ARVL
119
AZN
151
BDX
106
BGNE
192
BHC
110
BIIB
117
BMY
336
BRKR
107
CRL
96
CSTL
152
CYBN
127
EVOTF
108
FNCTF
336
GILD
273
GOOG
218
GOOGL
217
HZNP
139
IMAB
117
INCY
165
JNJ
1687
LCTX
101
LH
99
LLY
589
MCRB
102
MDT
138
MIRM
114
MOR
284
MPSYF
254
MRK
314
MRNA
289
MS
428
NKTR
287
NSTG
108
NVO
112
NVS
126
OCX
195
PFE
260
PRGO
118
PTCT
197
REGN
111
RLFTF
98
RLFTY
98
SNY
1709
SNYNF
1358
TAK
234
TECH
103
TEVJF
117
TMO
213
TWST
160
TXMD
227
VCYT
106
VRTX
111
VXRT
221
XNCR
101
Exchanges
Nasdaq
83
Nyse
112
Crawled Date
2023 - 10 - 30
2
2022 - 10 - 20
2
2022 - 09 - 29
2
2022 - 05 - 11
2
2022 - 04 - 12
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 18
1
2022 - 03 - 17
1
2022 - 02 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 17
1
2022 - 01 - 06
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 18
1
2021 - 11 - 16
1
2021 - 11 - 12
2
2021 - 11 - 10
1
2021 - 11 - 09
2
2021 - 11 - 04
1
2021 - 10 - 26
1
2021 - 10 - 19
1
2021 - 10 - 15
2
2021 - 09 - 28
1
2021 - 09 - 27
1
2021 - 09 - 24
1
2021 - 09 - 22
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 08 - 30
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 02
1
2021 - 07 - 29
1
2021 - 07 - 21
1
2021 - 07 - 12
1
2021 - 07 - 01
1
2021 - 06 - 22
2
2021 - 06 - 16
1
2021 - 06 - 09
1
2021 - 06 - 07
1
2021 - 06 - 03
1
2021 - 05 - 28
1
2021 - 05 - 27
1
2021 - 05 - 25
1
2021 - 05 - 24
1
2021 - 04 - 08
1
2021 - 03 - 29
1
2021 - 03 - 24
1
2021 - 03 - 18
2
2021 - 03 - 15
1
2021 - 03 - 11
1
2021 - 01 - 05
1
Crawled Time
06:00
3
07:00
12
08:00
13
09:00
7
10:00
6
11:00
8
12:00
10
12:15
6
12:20
1
12:30
4
13:00
9
13:15
2
14:00
10
14:30
1
15:00
2
15:20
1
16:00
1
17:00
5
18:00
2
19:00
2
21:00
3
22:00
4
Source
www.aspenpharma.com
1
www.biospace.com
112
www.globenewswire.com
342
www.prnewswire.com
176
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVO
source :
Www.biospace.com
save search
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published:
2024-04-17
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
0.87%
|
O:
1.22%
H:
0.21%
C:
-0.34%
vent-02
trial
therapeutics
results
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published:
2024-04-08
(Crawled : 12:30)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-0.35%
|
O:
1.62%
H:
0.5%
C:
0.36%
conference
therapeutics
Novo Holdings to Acquire Catalent
Published:
2024-02-05
(Crawled : 12:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
9.53%
|
O:
2.37%
H:
1.9%
C:
1.61%
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
3.22%
|
O:
-0.79%
H:
0.0%
C:
-0.8%
CTLT
|
$55.96
0.32%
0.0%
1.9M
|
Health Technology
|
2.33%
|
O:
8.81%
H:
1.5%
C:
0.86%
acquire
Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
Published:
2024-01-17
(Crawled : 14:30)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
17.09%
|
O:
-0.03%
H:
0.75%
C:
0.34%
diagnostics
platform
Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain
Published:
2024-01-03
(Crawled : 17:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
21.96%
|
O:
-0.06%
H:
1.75%
C:
1.54%
million
treatment
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
25.81%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.83%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
-9.27%
-10.21%
16K
|
Health Technology
|
-1.63%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
MapLight Therapeutics Closes $225 Million Series C Funding Round to Advance Pipeline of Central Nervous System Therapeutics
Published:
2023-10-30
(Crawled : 18:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
33.19%
|
O:
3.44%
H:
0.71%
C:
-0.33%
pipeline
series
system
therapeutics
funding
Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
Published:
2023-10-30
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
33.19%
|
O:
3.44%
H:
0.71%
C:
-0.33%
license
therapeutics
agreement
Orexo announces changes in the company´s Board of Directors - October 27, 2023
Published:
2023-10-27
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
30.81%
|
O:
-1.5%
H:
0.78%
C:
-0.29%
Cytoki Pharma Presents Preclinical Data Demonstrating Weight Reduction and Improved Glucose Control with Lipidated IL-22 at ObesityWeek 2023
Published:
2023-10-16
(Crawled : 19:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
21.92%
|
O:
-0.84%
H:
0.19%
C:
-0.13%
il-22
obesityweek
pharma
control
preclinical
FDA approves Rivfloza™ for children ≥9 years old and adults living with primary hyperoxaluria type 1 (PH1), a rare genetic condition
Published:
2023-10-02
(Crawled : 17:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
36.94%
|
O:
-0.85%
H:
3.13%
C:
1.81%
fda
rare
children
genetic
living
OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs
Published:
2023-09-20
(Crawled : 17:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
33.15%
|
O:
1.26%
H:
1.82%
C:
0.03%
therapeutics
Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
Published:
2023-06-29
(Crawled : 12:20)
- biospace.com/
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-3.63%
|
O:
1.06%
H:
0.72%
C:
0.72%
RLYB
|
News
|
$1.74
-3.33%
-3.45%
520K
|
|
-70.27%
|
O:
-0.34%
H:
4.41%
C:
-5.25%
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-20.58%
|
O:
-1.19%
H:
1.41%
C:
1.36%
CRL
|
$230.09
-0.97%
0.0%
500K
|
Commercial Services
|
12.93%
|
O:
0.09%
H:
1.73%
C:
1.58%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-3.8%
|
O:
-0.83%
H:
0.89%
C:
0.68%
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas
Published:
2023-06-22
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-22.43%
|
O:
-0.45%
H:
0.89%
C:
0.13%
fda
pancreas
clearance
insulin
Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
Published:
2023-05-16
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-26.5%
|
O:
-1.48%
H:
1.06%
C:
0.44%
ray
therapeutics
Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer
Published:
2023-04-18
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-27.21%
|
O:
-0.66%
H:
0.71%
C:
-0.09%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-12.62%
|
O:
-0.86%
H:
0.27%
C:
-1.97%
medical
Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
Published:
2023-03-16
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.02%
|
O:
-0.07%
H:
1.96%
C:
0.56%
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-11.67%
|
O:
-1.4%
H:
0.03%
C:
-0.08%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-2.12%
|
O:
1.01%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
-9.27%
-10.21%
16K
|
Health Technology
|
-21.97%
|
O:
-6.11%
H:
3.54%
C:
0.69%
pharma
conference
year
financial
Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024
Published:
2023-03-14
(Crawled : 19:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-11.39%
|
O:
1.15%
H:
0.65%
C:
0.56%
diabetes
living
insulin
Innate Pharma Provides Update on Silicon Valley Bank Exposure
Published:
2023-03-13
(Crawled : 09:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-11.86%
|
O:
-0.02%
H:
1.44%
C:
-0.51%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.46%
|
O:
-0.81%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
-9.27%
-10.21%
16K
|
Health Technology
|
-18.17%
|
O:
2.21%
H:
4.65%
C:
-1.66%
pharma
update
Zealand Pharma Announces Full Year Results for 2022
Published:
2023-03-02
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
-12.83%
|
O:
-0.53%
H:
1.28%
C:
1.06%
pharma
year
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.